KR20240099427A - 신규한 단백질 - Google Patents
신규한 단백질 Download PDFInfo
- Publication number
- KR20240099427A KR20240099427A KR1020247018665A KR20247018665A KR20240099427A KR 20240099427 A KR20240099427 A KR 20240099427A KR 1020247018665 A KR1020247018665 A KR 1020247018665A KR 20247018665 A KR20247018665 A KR 20247018665A KR 20240099427 A KR20240099427 A KR 20240099427A
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- fusion protein
- polypeptide
- disease
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2115803.5 | 2021-11-03 | ||
| GBGB2115803.5A GB202115803D0 (en) | 2021-11-03 | 2021-11-03 | Novel proteins |
| PCT/GB2022/052764 WO2023079278A1 (en) | 2021-11-03 | 2022-11-03 | Novel proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240099427A true KR20240099427A (ko) | 2024-06-28 |
Family
ID=78828504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247018665A Pending KR20240099427A (ko) | 2021-11-03 | 2022-11-03 | 신규한 단백질 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250026805A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4426719A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024542096A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240099427A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118369334A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022381844A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3236737A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202115803D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312470A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023079278A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2626300A (en) * | 2022-12-08 | 2024-07-24 | Ducentis Biotherapeutics Ltd | Mutated CD200 proteins and methods of use therof |
| GB202306711D0 (en) * | 2023-05-05 | 2023-06-21 | Ducentis Biotherapeutics Ltd | Novel proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5637481A (en) | 1993-02-01 | 1997-06-10 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| DE69226871T3 (de) | 1991-06-27 | 2009-09-24 | Bristol-Myers Squibb Co. | CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung |
| EP1171154A2 (en) | 1999-04-13 | 2002-01-16 | Schering Corporation | Uses of mammalian ox2 protein and related reagents |
| WO2008089022A2 (en) | 2007-01-11 | 2008-07-24 | Boehringer Ingelheim International Gmbh | Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts |
| GB201608197D0 (en) * | 2016-05-10 | 2016-06-22 | Ducentis Biotherapeutics Ltd | Novel proteins |
-
2021
- 2021-11-03 GB GBGB2115803.5A patent/GB202115803D0/en not_active Ceased
-
2022
- 2022-11-03 CA CA3236737A patent/CA3236737A1/en active Pending
- 2022-11-03 JP JP2024526578A patent/JP2024542096A/ja active Pending
- 2022-11-03 EP EP22802232.3A patent/EP4426719A1/en active Pending
- 2022-11-03 US US18/707,321 patent/US20250026805A1/en active Pending
- 2022-11-03 IL IL312470A patent/IL312470A/en unknown
- 2022-11-03 AU AU2022381844A patent/AU2022381844A1/en active Pending
- 2022-11-03 KR KR1020247018665A patent/KR20240099427A/ko active Pending
- 2022-11-03 WO PCT/GB2022/052764 patent/WO2023079278A1/en not_active Ceased
- 2022-11-03 CN CN202280081085.3A patent/CN118369334A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023079278A1 (en) | 2023-05-11 |
| IL312470A (en) | 2024-06-01 |
| EP4426719A1 (en) | 2024-09-11 |
| CA3236737A1 (en) | 2023-05-11 |
| GB202115803D0 (en) | 2021-12-15 |
| JP2024542096A (ja) | 2024-11-13 |
| CN118369334A (zh) | 2024-07-19 |
| US20250026805A1 (en) | 2025-01-23 |
| AU2022381844A1 (en) | 2024-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102689460B1 (ko) | Cd200 돌연변이체 및 그의 용도 | |
| US12173046B2 (en) | TNFR2 agonists with improved stability | |
| KR20160130463A (ko) | 다량체 Fc 단백질 | |
| US20250026805A1 (en) | Novel proteins | |
| US20260116946A1 (en) | Novel cd200 fusion proteins | |
| KR20260007620A (ko) | Cd200 융합 단백질 | |
| US20260116951A1 (en) | Novel cd200 fusion proteins | |
| JP7829127B2 (ja) | 抗原結合ドメインおよびサイトカイン三量体ドメインを含む融合タンパク質 | |
| HK40072147B (en) | Tnfr2 agonists with improved stability | |
| HK40072147A (en) | Tnfr2 agonists with improved stability | |
| EA042608B1 (ru) | Мутант cd200 и его применения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |